|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
11,270,000 |
Market
Cap: |
287.16(M) |
Last
Volume: |
197,427 |
Avg
Vol: |
195,579 |
52
Week Range: |
$13.82 - $29.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile XOMA is a biotech royalty aggregator. Co. has a portfolio of economic rights to milestone and royalty payments associated with partnered pre-commercial therapeutic candidates. Co.'s portfolio was built through licensing its proprietary products and platforms from its discovery and development business, combined with acquisitions of rights to milestones and royalties.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,249 |
44,891 |
Total Buy Value |
$0 |
$0 |
$74,739 |
$824,245 |
Total People Bought |
0 |
0 |
2 |
3 |
Total Buy Transactions |
0 |
0 |
4 |
17 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sitko Bradley |
Chief Investment Officer |
|
2023-10-03 |
4 |
B |
$13.89 |
$3,473 |
D/D |
250 |
5,600 |
0.01 |
51% |
|
Sitko Bradley |
Chief Investment Officer |
|
2023-10-02 |
4 |
B |
$14.25 |
$21,375 |
D/D |
1,500 |
5,350 |
0.01 |
46% |
|
Hughes Owen |
Exec Chairman and Interim CEO |
|
2023-10-02 |
4 |
B |
$13.83 |
$13,830 |
D/D |
1,000 |
3,500 |
0.01 |
46% |
|
Hughes Owen |
Exec Chairman and Interim CEO |
|
2023-09-26 |
4 |
B |
$14.43 |
$36,061 |
D/D |
2,499 |
2,500 |
0.01 |
41% |
|
Hughes Owen |
Exec Chairman and Interim CEO |
|
2023-09-25 |
4 |
B |
$14.65 |
$15 |
D/D |
1 |
1 |
0.01 |
38% |
|
Sitko Bradley |
Chief Investment Officer |
|
2023-05-31 |
4 |
B |
$17.00 |
$25,700 |
I/I |
1,500 |
3,500 |
0.01 |
-10% |
|
Hughes Owen |
Interim CEO |
|
2023-05-24 |
4 |
B |
$23.79 |
$24,551 |
D/D |
1,032 |
2,000 |
0.01 |
-22% |
|
Hughes Owen |
Interim CEO |
|
2023-05-23 |
4 |
B |
$23.33 |
$22,706 |
D/D |
968 |
968 |
0.01 |
-24% |
|
Sitko Bradley |
Chief Investment Officer |
|
2023-05-23 |
4 |
B |
$19.00 |
$16,150 |
D/D |
850 |
3,850 |
0.01 |
-24% |
|
Sitko Bradley |
Chief Investment Officer |
|
2023-05-19 |
4 |
B |
$19.50 |
$19,500 |
D/D |
1,000 |
3,000 |
0.01 |
-27% |
|
Sitko Bradley |
Chief Investment Officer |
|
2023-05-16 |
4 |
B |
$23.19 |
$11,602 |
I/I |
500 |
2,000 |
0.01 |
-28% |
|
Sitko Bradley |
Chief Investment Officer |
|
2023-05-15 |
4 |
B |
$23.40 |
$35,100 |
I/I |
1,500 |
1,500 |
0.01 |
-22% |
|
Sitko Bradley |
Chief Investment Officer |
|
2023-05-12 |
4 |
B |
$18.66 |
$37,985 |
D/D |
2,000 |
2,000 |
0.01 |
-18% |
|
Lampert Mark N |
Director |
|
2023-01-06 |
4 |
B |
$21.98 |
$71,419 |
D/D |
3,249 |
1,618,637 |
3.92 |
-3% |
|
Lampert Mark N |
Director |
|
2023-01-05 |
4 |
B |
$18.39 |
$349,319 |
D/D |
19,000 |
1,617,064 |
3.92 |
-6% |
|
Lampert Mark N |
Director |
|
2022-09-27 |
4 |
B |
$16.89 |
$28,409 |
D/D |
1,682 |
1,601,394 |
3.92 |
20% |
|
Lampert Mark N |
Director |
|
2022-09-26 |
4 |
B |
$16.83 |
$107,050 |
D/D |
6,360 |
1,600,716 |
3.92 |
22% |
|
Lampert Mark N |
Director |
|
2022-09-23 |
4 |
B |
$16.50 |
$273,850 |
D/D |
16,600 |
1,597,695 |
3.92 |
20% |
|
Lampert Mark N |
Director |
|
2022-09-16 |
4 |
B |
$17.89 |
$434,536 |
D/D |
24,293 |
1,773,780 |
3.92 |
18% |
|
Lampert Mark N |
Director |
|
2022-09-15 |
4 |
B |
$17.96 |
$100,138 |
D/D |
5,575 |
1,576,913 |
3.92 |
14% |
|
Lampert Mark N |
Director |
|
2022-09-14 |
4 |
B |
$17.25 |
$456,044 |
D/D |
26,441 |
1,571,338 |
3.92 |
18% |
|
Burns Thomas M. |
SVP, Finance & CFO |
|
2022-07-15 |
4 |
AS |
$31.66 |
$63,321 |
D/D |
(2,000) |
6,555 |
|
-18% |
|
Burns Thomas M. |
SVP, Finance & CFO |
|
2022-07-15 |
4 |
OE |
$4.03 |
$8,060 |
D/D |
2,000 |
8,555 |
|
- |
|
Neal James R |
CEO |
|
2022-07-15 |
4 |
AS |
$29.55 |
$746,104 |
D/D |
(25,000) |
11,822 |
|
-18% |
|
Neal James R |
CEO |
|
2022-07-15 |
4 |
OE |
$4.03 |
$100,750 |
D/D |
25,000 |
36,822 |
|
- |
|
354 Records found
|
|
Page 1 of 15 |
|
|